Literature DB >> 15692250

Elevated clotting factor levels and venous thrombosis.

Rogier M Bertina1.   

Abstract

Increased plasma levels of fibrinogen, factor VIII (FVIII), factor IX (FIX), factor XI (FXI) and prothrombin all were reported to be independent risk factors of venous thromboembolism (VTE). However there is only limited information on the molecular basis of these plasma phenotypes. In addition some of these plasma phenotypes may form clusters, which may point to defects in common pathways affecting biosynthesis or clearance. Uncertainties as to what should be considered the cut-off for an elevated plasma level and in some cases (FIX, FXI) the lack of published confirmatory and/or prospective studies, have delayed the incorporation of these parameters in thrombophilia screening procedures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15692250     DOI: 10.1159/000083835

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  14 in total

1.  Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.

Authors:  Scott Cooper; Shawn Sell; Luke Nelson; Jennifer Hawes; Jacob A Benrud; Bridget M Kohlnhofer; Bradley R Burmeister; Veronica H Flood
Journal:  J Comp Physiol B       Date:  2016-01       Impact factor: 2.200

Review 2.  Venous thromboembolism.

Authors:  Andrew D Blann; Gregory Y H Lip
Journal:  BMJ       Date:  2006-01-28

3.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

4.  Factor IX and deep vein thrombosis.

Authors:  Gordon Lowe
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

Review 5.  The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.

Authors:  Allison P Wheeler; David Gailani
Journal:  Hematol Oncol Clin North Am       Date:  2016-10       Impact factor: 3.722

Review 6.  Introduction to haemostasis from a pharmacodynamic perspective.

Authors:  Cornelis Kluft; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

7.  Coagulation factor VIII levels are associated with long-term survival - interactions with gender in a large hospital-based cohort.

Authors:  Florian M Kovar; Claudia L Marsik; Christian Joukhadar; Thomas Perkmann; Helmuth Haslacher; Thomas Schickbauer; Paul A Kyrle; Oswald F Wagner; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2010-06-25       Impact factor: 1.704

Review 8.  Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

Authors:  Jonathan Stone; Patrick Hangge; Hassan Albadawi; Alex Wallace; Fadi Shamoun; M Grace Knuttien; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

9.  Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer.

Authors:  Junichi Kodama; Noriko Seki; Chikako Fukushima; Tomoyuki Kusumoto; Keiichiro Nakamura; Atsushi Hongo; Yuji Hiramatsu
Journal:  Oncol Lett       Date:  2012-10-15       Impact factor: 2.967

Review 10.  Antibodies to serine proteases in the antiphospholipid syndrome.

Authors:  Pojen P Chen; Ian Giles
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.